December 19, 2022
The Vaccine Adverse Event Reporting System (VAERS) is a national early warning system to detect possible safety problems in U.S.-licensed vaccines.VAERS is widely acknowledged, even by the CDC, to be vastly underreported. From their Dataguide:
"'Underreporting' is one of the main limitations of passive surveillance systems, including VAERS. The term, underreporting, refers to the fact that VAERS receives reports for only a small fraction of actual adverse events.
Further it states, "Adverse events from drugs and vaccines are common, but underreported. Although 25% of ambulatory patients experience an adverse drug event, less than 0.3% of all adverse drug events and 1-13% of serious events are reported to the Food and Drug Administration (FDA). Likewise, fewer than 1% of vaccine adverse events are reported."
The results clearly showed that injury was much more common than the one-in-a-million lie that is often cited.
More recently Steve Kirsch and Dr. Jessica Rose have both calculated an Under Reporting Factor (URF) for Covid vaccine injuries. Steve used multiple methods to confirm a URF of approximately 41. Dr. Rose used of the current Department of Defense Medical Epidemiology Database (DMED) miscarriage rates to calculate a URF of 49.
Established in 1990, the Vaccine Adverse Event Reporting System (VAERS) is a national early warning system to detect possible safety problems in U.S.-licensed vaccines. VAERS is co-managed by the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA). VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination. Anyone can report an adverse event to VAERS. Healthcare professionals are required to report certain adverse events and vaccine manufacturers are required to report all adverse events that come to their attention.
VAERS is a passive reporting system, meaning it relies on individuals to send in reports of their experiences to CDC and FDA. VAERS is not designed to determine if a vaccine caused a health problem, but is especially useful for detecting unusual or unexpected patterns of adverse event reporting that might indicate a possible safety problem with a vaccine. This way, VAERS can provide CDC and FDA with valuable information that additional work and evaluation is necessary to further assess a possible safety concern.